Willis J Kevin reported grant involving 405 shares of Ingevity Corp at $71.09 for $28.8k on Oct 1, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Oct 2, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$28,791.45Shares × reported price
Shares traded
405Common Stock
Price per share
$71.09Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
11,883Direct
Trade date
Oct 1, 2026Grant
Filed
Oct 2, 2026, 6:45 PM ET1-day reporting delay
Accession
0001575329-26-000011Code A · Transaction 235857
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

NGVT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
NGVT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −5.4%1w ago −0.9%1d ago −2.3%
Returns since7d −3.7%30d +2.6%90d180d1y

Footnotes in full

F1: Represents vested deferred stock units ("DSUs") granted pursuant to the reporting person's election to receive DSUs in lieu of quarterly director fees. These DSUs will settle into an equal number of shares of the Company's Common Stock upon the reporting person's termination of board service pursuant to the Company's Amended and Restated Non-Employee Director Deferred Compensation Plan and 2025 Omnibus Incentive Plan, as amended.